Towards curative therapy in gastric cancer: Faraway, so close!

doi:10.3748/wjg.v21.i41.11609

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 21, Issue 41

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (9536)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series, Tables (1-4) series.

Item

Count

PDF

496

WORD

357

HTML

4608

Figures (1-2)

280

Tables (1-4)

271

Sum=6012

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

446

Download

864

Sum=1310

Publishing Process of This Article

Item

Count

Browse

952

Download

1262

Sum=2214

Nov 7, 2015 (publication date) through Jan 22, 2025

Times Cited of This Article

Times Cited (9)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Topic Highlight

World J Gastroenterol. Nov 7, 2015; 21(41): 11609-11620
Published online Nov 7, 2015. doi: 10.3748/wjg.v21.i41.11609

Table 2 Randomized trials of adjuvant chemo or chemoradiotherapy in resected gastric cancer

Ref.	n	Regimen	3 yr Disease free survival rate (%; P value)
Lee et al[41], 2012	458	XP vs XP/XRT/XP	No significant Disease free survival difference
Yu et al[45], 2012	68	5FU/LV vs 5FU /LV/RT	44.1 vs 67.7 (P < 0.05)
Kim et al[44], 2012	90	5FU/LV vs 5FU/LV/RT	No significant Disease free survival difference
Kwon et al[46], 2010	61	5FU/LV vs 5FU/LV/RT	No significant Disease free survival difference
Bamias et al[43], 2010	147	DP vs DP/RT	No significant Disease free survival difference

X: Capecitabine; 5-FU: 5-fluorouracil; LV: Leucovorin; P: Cisplatin; D: docetaxel; RT: Radiotherapy (45 Gy).

Citation: Cravo M, Fidalgo C, Garrido R, Rodrigues T, Luz G, Palmela C, Santos M, Lopes F, Maio R. Towards curative therapy in gastric cancer: Faraway, so close! World J Gastroenterol 2015; 21(41): 11609-11620
URL: https://www.wjgnet.com/1007-9327/full/v21/i41/11609.htm
DOI: https://dx.doi.org/10.3748/wjg.v21.i41.11609